Equities Analysts Offer Predictions for MGRM Q3 Earnings

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Equities research analysts at Zacks Small Cap issued their Q3 2025 EPS estimates for shares of Monogram Orthopaedics in a research note issued to investors on Thursday, March 13th. Zacks Small Cap analyst T. Kerr forecasts that the company will earn ($0.11) per share for the quarter. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share.

Monogram Orthopaedics (NASDAQ:MGRM) last released its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.03.

A number of other research analysts have also issued reports on the stock. Roth Capital upgraded shares of Monogram Orthopaedics to a “strong-buy” rating in a research note on Monday, December 9th. Roth Mkm assumed coverage on shares of Monogram Orthopaedics in a research note on Monday, December 9th. They issued a “buy” rating and a $4.00 target price for the company.

Monogram Orthopaedics Trading Up 0.9 %

NASDAQ MGRM opened at $2.33 on Friday. The stock has a market cap of $79.95 million, a price-to-earnings ratio of -4.96 and a beta of 1.66. The company has a 50-day moving average price of $2.54 and a two-hundred day moving average price of $2.49. Monogram Orthopaedics has a 52 week low of $1.53 and a 52 week high of $4.90.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of MGRM. Jane Street Group LLC acquired a new position in Monogram Orthopaedics during the fourth quarter valued at approximately $25,000. Wells Fargo & Company MN grew its stake in shares of Monogram Orthopaedics by 286.6% in the fourth quarter. Wells Fargo & Company MN now owns 11,597 shares of the company’s stock valued at $27,000 after acquiring an additional 8,597 shares in the last quarter. Barclays PLC bought a new position in Monogram Orthopaedics in the 3rd quarter valued at about $29,000. Orion Portfolio Solutions LLC bought a new position in Monogram Orthopaedics in the 4th quarter valued at about $31,000. Finally, State Street Corp acquired a new stake in shares of Monogram Orthopaedics in the 3rd quarter valued at approximately $62,000. Institutional investors and hedge funds own 0.45% of the company’s stock.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.